{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "CNY", "regularMarketChangePercent": 2.9893966, "regularMarketPrice": 10.68, "earningsTimestamp": 1618916340, "earningsTimestampStart": 1650538740, "earningsTimestampEnd": 1650628800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.45, "epsForward": 0.77, "sharesOutstanding": 475358016, "bookValue": 2.848, "fiftyDayAverage": 11.3362, "fiftyDayAverageChange": -0.65619946, "fiftyDayAverageChangePercent": -0.05788531, "twoHundredDayAverage": 12.24455, "twoHundredDayAverageChange": -1.5645494, "twoHundredDayAverageChangePercent": -0.12777518, "marketCap": 5076823552, "forwardPE": 13.870131, "priceToBook": 3.75, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1302831000000, "priceHint": 2, "marketState": "POSTPOST", "exchange": "SHZ", "shortName": "STAIDSON (BEIJING)", "longName": "Staidson (Beijing) BioPharmaceuticals Co., Ltd.", "messageBoardId": "finmb_118531133", "exchangeTimezoneName": "Asia/Shanghai", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "cn_market", "esgPopulated": false, "regularMarketChange": 0.31000042, "regularMarketTime": 1683875080, "regularMarketDayHigh": 11.09, "regularMarketDayRange": "10.44 - 11.09", "regularMarketDayLow": 10.44, "regularMarketVolume": 16620200, "regularMarketPreviousClose": 10.37, "bid": 10.67, "ask": 10.68, "bidSize": 0, "askSize": 0, "fullExchangeName": "Shenzhen", "financialCurrency": "CNY", "regularMarketOpen": 10.45, "averageDailyVolume3Month": 12015541, "averageDailyVolume10Day": 12555250, "fiftyTwoWeekLowChange": 1.1599998, "fiftyTwoWeekLowChangePercent": 0.12184872, "fiftyTwoWeekRange": "9.52 - 19.5", "fiftyTwoWeekHighChange": -8.82, "fiftyTwoWeekHighChangePercent": -0.45230767, "fiftyTwoWeekLow": 9.52, "fiftyTwoWeekHigh": 19.5, "symbol": "300204.SZ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 36, Jinghai Er Road", "address2": "Beijing Economic and Technological Development Zone", "city": "Beijing", "zip": "100176", "country": "China", "phone": "86 10 6751 9888", "fax": "86 10 6751 9794", "website": "https://www.staidson.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; gene therapy/cell therapy drugs; and chemical drugs. It principally offers its products under the fields of nervous system related, infectious, gastrointestinal, urinary system, and autoimmune diseases. The company has a strategic collaboration with Pivotal S.L. to assess BDB-001, a monoclonal anti-C5a antibody, in a clinical trial in Europe in progressive severe COVID-19 patients caused by SARS-CoV-2. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.", "fullTimeEmployees": 803, "companyOfficers": [{"maxAge": 1, "name": "Mr. Zhi Wen  Zhou", "age": 57, "title": "Chairman & Sec.", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Wang  Chao", "age": 40, "title": "Gen. Mang.", "yearBorn": 1982, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Shicheng  Li", "age": 40, "title": "Financial Controller", "yearBorn": 1982, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}